Clinical Performance Evaluation of Pefakit® PiCT® UC In Vitro Diagnostic Medical Device

CompletedOBSERVATIONAL
Enrollment

123

Participants

Timeline

Start Date

April 30, 2012

Primary Completion Date

May 31, 2013

Study Completion Date

May 31, 2013

Conditions
Thromboembolic Events
Trial Locations (3)

65191

Deutsche Klinik für Diagnostik, Wiesbaden

73104

University of Oklahoma Health Sciences Center, Oklahoma City

CH-9007

Cantonal Hospital -Institue for Clinical Chemistry and hematology, Sankt Gallen

All Listed Sponsors
lead

DSM Nutritional Products, Inc.

INDUSTRY

NCT02052544 - Clinical Performance Evaluation of Pefakit® PiCT® UC In Vitro Diagnostic Medical Device | Biotech Hunter | Biotech Hunter